Literature DB >> 22965276

Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis.

Jennifer J Speirs1, Cornelis K van der Ent, Jeffrey M Beekman.   

Abstract

PURPOSE OF REVIEW: Aspergillus fumigatus is frequently isolated from cystic fibrosis (CF) patients and is notorious for its role in the debilitating condition of allergic bronchopulmonary aspergillosis (ABPA). Although CF patients suffer from perpetual microorganism-related lung disease, it is unclear whether A. fumigatus colonization has a role in causing accelerated lung function decline and whether intervention is necessary. RECENT
FINDINGS: A. fumigatus morbidity appears to be related to cystic fibrosis transmembrane conductance regulator-dependant function of the innate immune system. A. fumigatus-colonized patients have a lower lung capacity, more frequent hospitalizations and more prominent radiological abnormalities than noncolonized patients. Treatment with antifungal agents can be of value but has several drawbacks and a direct effect on lung function is yet to be shown.
SUMMARY: A. fumigatus appears to have an important role in CF lung disease, not exclusive to the context of ABPA. However, a causal relationship still needs to be confirmed. Study observations and trends indicate a need to further elucidate the mechanisms of A. fumigatus interactions with the host innate immune system and its role in CF lung morbidity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965276     DOI: 10.1097/MCP.0b013e328358d50b

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  18 in total

1.  Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis.

Authors:  A Oliva; P Flori; C Hennequin; J-C Dubus; M Reynaud-Gaubert; D Charpin; J M Vergnon; P Gay; A Colly; R Piarroux; H Pelloux; S Ranque
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.

Authors:  M Noni; A Katelari; G Dimopoulos; S-E Doudounakis; C Tzoumaka-Bakoula; V Spoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-08-30       Impact factor: 3.267

3.  Effect of Media Modified To Mimic Cystic Fibrosis Sputum on the Susceptibility of Aspergillus fumigatus, and the Frequency of Resistance at One Center.

Authors:  David A Stevens; Richard B Moss; Cathy Hernandez; Karl V Clemons; Marife Martinez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Studies of Pseudomonas aeruginosa Mutants Indicate Pyoverdine as the Central Factor in Inhibition of Aspergillus fumigatus Biofilm.

Authors:  Gabriele Sass; Hasan Nazik; John Penner; Hemi Shah; Shajia Rahman Ansari; Karl V Clemons; Marie-Christine Groleau; Anna-Maria Dietl; Paolo Visca; Hubertus Haas; Eric Déziel; David A Stevens
Journal:  J Bacteriol       Date:  2017-12-05       Impact factor: 3.490

5.  Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients.

Authors:  J Steinmann; S Giraud; D Schmidt; L Sedlacek; A Hamprecht; J Houbraken; J F Meis; J P Bouchara; J Buer; P-M Rath
Journal:  New Microbes New Infect       Date:  2014-04-20

Review 6.  Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.

Authors:  Anjali Y Bhagirath; Yanqi Li; Deepti Somayajula; Maryam Dadashi; Sara Badr; Kangmin Duan
Journal:  BMC Pulm Med       Date:  2016-12-05       Impact factor: 3.317

7.  Harnessing Bacterial Signals for Suppression of Biofilm Formation in the Nosocomial Fungal Pathogen Aspergillus fumigatus.

Authors:  F Jerry Reen; John P Phelan; David F Woods; Rachel Shanahan; Rafael Cano; Sarah Clarke; Gerard P McGlacken; Fergal O'Gara
Journal:  Front Microbiol       Date:  2016-12-22       Impact factor: 5.640

8.  Association between spirometry controlled chest CT scores using computer-animated biofeedback and clinical markers of lung disease in children with cystic fibrosis.

Authors:  Thomas Kongstad; Kent Green; Frederik Buchvald; Marianne Skov; Tania Pressler; Kim Gjerum Nielsen
Journal:  Eur Clin Respir J       Date:  2017-05-02

9.  The lung mycobiome: an emerging field of the human respiratory microbiome.

Authors:  Linh D N Nguyen; Eric Viscogliosi; Laurence Delhaes
Journal:  Front Microbiol       Date:  2015-02-13       Impact factor: 5.640

10.  Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium.

Authors:  Jose A G Ferreira; John C Penner; Richard B Moss; Janus A J Haagensen; Karl V Clemons; Alfred M Spormann; Hasan Nazik; Kevin Cohen; Niaz Banaei; Elisabete Carolino; David A Stevens
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.